January 2017
Oncology
Peer Reviewed | Web-Exclusive

Sign in to continue reading this article

Not registered? Create an account for free to read full articles on www.cliniciansbrief.com.

To access full articles on www.cliniciansbrief.com, please sign in below.

Busy? Sign in Faster. Sign into www.cliniciansbrief.com with your social media account.

This quiz reviews staging, treatment (including vaccination), and prognosis of melanoma in dogs and cats. Dermal, oral, lip, subungual, and amelanotic melanomas are covered.

...  Questions
Multiple Choice Questions
Questions  .../...
Score  .../...

Quiz: Melanoma

Quiz: Melanoma

Final score
... of ...
Take this quiz by answering the following multiple choice questions. Start Quiz
Quiz: Melanoma
Previous Next Submit Finish
References and author information Show
References
  1. Bergman PJ, Kent MS, Farese JP. Melanoma. In: Withrow J, Vail DM, Page RL, eds. Withrow & MacEwen’s Small Animal Clinical Oncology. 5th ed. St. Louis, MO: Elsevier Saunders; 2013:321-334.
  2. Friedrichs KR, Young KM. Diagnostic cytopathology in clinical oncology. In: Withrow J, Vail DM, Page RL, eds. Withrow & MacEwen’s Small Animal Clinical Oncology. 5th ed. St. Louis, MO: Elsevier Saunders; 2013:111-132.
  3. Moore AS. Staging melanoma of the oral cavity or skin in dogs. Clin Brief. 2008;6(6):27-30.
  4. Williams LE, Packer RA. Association between lymph node size and metastasis in dogs with oral malignant melanoma: 100 cases (1987-2001). J Am Vet Med Assoc. 2003;222(9):1234-1236.
  5. Bergin IL, Smedley RC, Esplin DG, Spangler WL, Kiupel M. Prognostic evaluation of Ki67 threshold value in canine oral melanoma. Vet Pathol. 2011;48(1):41-53.
  6. Bergman PJ, McKnight J, Novosad A, et al. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogenic human tyrosinase: a phase I trial. Clin Cancer Re. 2003;9(4):1284-1290. 
  7. Smeadley RC, Spangler WL, Esplin DG, et al. Prognostic markers for canine melanocytic neoplasms: a comparative review of the literature and goals for future investigation. Vet Pathol. 2011;48(1):54-72.
  8. Smith SH, Goldschmidt MH, McManus PM. A comparative review of melanocytic neoplasms. Vet Pathol. 2002;39(6):651-678.
  9. Bergman PJ, Camps-Palau MA, McKnight JA, et al. Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine. 2006;24:4582-4585.
  10. Grosebaug DA, Leard AT, Bergman PJ, et al. Safety and efficacy of a xenogenic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor. Am J Vet Res. 2011;72(12):1631-1638.
  11. Oncept Canine Melanoma Vaccine (product insert). Duluth, GA: Merial US, 2009; for more information, http://www.petcancervaccine.com/vaccine/Pages/default.aspx.
  12. Guth AM, Dow S. Cancer immunotherapy. In: Withrow J, Vail DM, Page RL, eds. Withrow & MacEwen’s Small Animal Clinical Oncology. 5th ed. St. Louis, MO: Elsevier Saunders; 2013:198-214. 
  13. Phillips JC, Lembcke LM, Noltenius CE, et al. Evaluation of tyrosinase expression in canine and equine melanocytic tumors. Am J Vet Res. 2012;73(2):272-278.
  14. Sarbu L, Kitchell BE, Bergman PJ. Safety of administering the canine melanoma DNA vaccine (Oncept) to cats with malignant melanoma—a retrospective study. J Feline Med Surg. 2015;18:1-7[Epub ahead of print].
  15. Henry CJ, Brewer WG Jr, Whitley EM, Veterinary Cooperative Oncology Group (VCOG), et al. Canine digital tumors: a veterinary cooperative oncology group retrospective study of 64 dogs. J Vet Intern Med. 2005;19(5):720-724.
Authors

Rebekah Lewis

DVM, MS Veterinary Oncology & Referral Clinic, Milford, Ohio

Rebekah Lewis, DVM, MS, is affiliated with Veterinary Oncology & Referral Clinic in Milford, Ohio. Her areas of clinical interest include medical and radiation oncology. Dr. Lewis received her veterinary degree from The Ohio State University, followed by completing a rotating internship at University of Illinois and oncology residency at Washington State University. She has previously published in the Journal of Comparative Oncology.

Cheryl Harris

DVM, DACVIM (Oncology) Veterinary Oncology & Referral Clinic, Milford, Ohio

Cheryl Harris, DVM, DACVIM (Oncology) is affiliated with Veterinary Oncology & Referral Clinic in Milford, Ohio. Her areas of clinical interest include internal medicine and medical oncology. Dr. Harris received her veterinary degree from The Ohio State University, followed by completing a rotating internship at University of Minnesota and internal medicine residency at University of Illinois.  She has previously published in the Veterinary Immunology and Immunopathology, the Compendium of Continuing Education Practice Veterinary, the Journal of the American Animal Hospital Association, The Veterinary Clinics of North America (Small Animal Practice), the Journal of Veterinary Internal Medicine, and the Journal of Veterinary Diagnostic Investigation.

Material from Clinician’s Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.

Up Next